Actipulse Neuroscience

Actipulse Neuroscience is revolutionizing mental health treatment by bringing non-invasive brain stimulation therapy from the confines of hospitals into the comfort of patients' homes. This innovative approach addresses the limitations of traditional brain stimulation, an FDA-cleared treatment widely used for depression, which is typically restricted to hospital settings due to high device costs and complex application procedures. Actipulse's proprietary device enables patients to receive effective treatment at home, offering comparable efficacy at a significantly reduced cost. The company is currently undergoing an FDA pivotal phase for Major Depressive Disorder and a pilot phase for Alzheimer's and Parkinson's diseases, demonstrating its commitment to expanding access to vital neurological therapies.